Lehman Financial Resources’s Teva Pharmaceuticals TEVA Stock Holding History

Lehman Financial Resources’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-1,600	Closed	-$90K	–	310
2015 Q3	$90K	Sell	1,600 -200	-11%	-$13K	0.05%	103
2015 Q2	$106K	Hold	1,800	–	–	0.05%	90
2015 Q1	$112K	Hold	1,800	–	–	0.05%	91
2014 Q4	$104K	Hold	1,800	–	–	0.05%	93
2014 Q3	$97K	Hold	1,800	–	–	0.05%	96
2014 Q2	$94K	Hold	1,800	–	–	0.04%	98
2014 Q1	$95K	Sell	1,800 -600	-25%	-$27.7K	0.05%	95
2013 Q4	$96K	Hold	2,400	–	–	0.06%	84
2013 Q3	$91K	Hold	2,400	–	–	0.06%	83
2013 Q2	$94K	Buy	+2,400	New	+$93.5K	0.06%	75

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Lehman Financial Resources's TEVA Position: Q4 2015 in Review

Lehman Financial Resources sold out of Teva Pharmaceuticals (TEVA) in Q4 2015, closing a stake of 1,600 shares — an estimated $90K sold.

Lehman Financial Resources first reported a position in TEVA in Q2 2013 and held it in 10 quarters. The position peaked at $112K in Q1 2015. 876 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

Lehman Financial Resources reported no remaining Teva Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Lehman Financial Resources sold 1,600 Teva Pharmaceuticals shares in Q4 2015, an estimated $90K.
Lehman Financial Resources first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 10 quarters.
Lehman Financial Resources's Teva Pharmaceuticals position peaked at $112K in Q1 2015.
876 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on Lehman Financial Resources's 13F filing for Q4 2015, filed 17 Feb 2016.